Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Grasim Industries Limited stock logo
GRSXY
Grasim Industries
$19.61
$19.61
$19.61
$19.61
$13.35B-0.16N/AN/A
The Japan Steel Works, Ltd. stock logo
JPSWY
Japan Steel Works
$25.10
-1.9%
$21.72
$11.23
$29.54
$3.74B0.45133 shs15 shs
MTN Group Limited stock logo
MTNOY
MTN Group
$7.45
-2.1%
$6.54
$3.92
$7.72
$13.45B1.2231,554 shs10,002 shs
Sino Biopharmaceutical Limited stock logo
SBMFF
Sino Biopharmaceutical
$0.70
-3.3%
$0.51
$0.31
$0.77
$13.24B0.552,456 shs5,000 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Grasim Industries Limited stock logo
GRSXY
Grasim Industries
0.00%0.00%0.00%0.00%0.00%
The Japan Steel Works, Ltd. stock logo
JPSWY
Japan Steel Works
0.00%+3.60%+22.44%+23.65%+75.28%
MTN Group Limited stock logo
MTNOY
MTN Group
0.00%+1.36%+12.23%+18.46%+68.10%
Sino Biopharmaceutical Limited stock logo
SBMFF
Sino Biopharmaceutical
0.00%+27.48%+42.34%+66.18%+90.43%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Grasim Industries Limited stock logo
GRSXY
Grasim Industries
N/AN/AN/AN/AN/AN/AN/AN/A
The Japan Steel Works, Ltd. stock logo
JPSWY
Japan Steel Works
N/AN/AN/AN/AN/AN/AN/AN/A
MTN Group Limited stock logo
MTNOY
MTN Group
N/AN/AN/AN/AN/AN/AN/AN/A
Sino Biopharmaceutical Limited stock logo
SBMFF
Sino Biopharmaceutical
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Grasim Industries Limited stock logo
GRSXY
Grasim Industries
0.00
N/AN/AN/A
The Japan Steel Works, Ltd. stock logo
JPSWY
Japan Steel Works
0.00
N/AN/AN/A
MTN Group Limited stock logo
MTNOY
MTN Group
0.00
N/AN/AN/A
Sino Biopharmaceutical Limited stock logo
SBMFF
Sino Biopharmaceutical
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Grasim Industries Limited stock logo
GRSXY
Grasim Industries
$15.98B0.84$1.88 per share10.43$24.50 per share0.80
The Japan Steel Works, Ltd. stock logo
JPSWY
Japan Steel Works
$1.75B2.14$1.34 per share18.69$8.37 per share3.00
MTN Group Limited stock logo
MTNOY
MTN Group
$12.00B1.12$0.20 per share36.43$4.51 per share1.65
Sino Biopharmaceutical Limited stock logo
SBMFF
Sino Biopharmaceutical
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Grasim Industries Limited stock logo
GRSXY
Grasim Industries
$674.94M$0.7028.01N/A2.74%2.78%0.94%8/7/2025 (Estimated)
The Japan Steel Works, Ltd. stock logo
JPSWY
Japan Steel Works
$98.53M$0.8031.7722.21N/A7.01%10.56%5.18%8/4/2025 (Estimated)
MTN Group Limited stock logo
MTNOY
MTN Group
$221.79MN/A0.00N/AN/AN/AN/AN/A
Sino Biopharmaceutical Limited stock logo
SBMFF
Sino Biopharmaceutical
N/AN/A0.00N/AN/AN/AN/A8/11/2025 (Estimated)

Latest JPSWY, SBMFF, GRSXY, and MTNOY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/22/2025Q4 2025
Grasim Industries Limited stock logo
GRSXY
Grasim Industries
N/A$0.26N/A$0.26N/A$5.16 billion
5/13/2025Q4 2025
The Japan Steel Works, Ltd. stock logo
JPSWY
Japan Steel Works
N/A$0.22N/A$0.25N/A$497.32 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Grasim Industries Limited stock logo
GRSXY
Grasim Industries
$0.100.51%N/A14.29%N/A
The Japan Steel Works, Ltd. stock logo
JPSWY
Japan Steel Works
$0.070.28%N/A8.75%N/A
MTN Group Limited stock logo
MTNOY
MTN Group
$0.121.61%N/AN/AN/A
Sino Biopharmaceutical Limited stock logo
SBMFF
Sino Biopharmaceutical
N/AN/AN/AN/AN/A

Latest JPSWY, SBMFF, GRSXY, and MTNOY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/17/2025
MTN Group Limited stock logo
MTNOY
MTN Group
$0.19074/11/20254/11/20254/24/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Grasim Industries Limited stock logo
GRSXY
Grasim Industries
N/AN/AN/A
The Japan Steel Works, Ltd. stock logo
JPSWY
Japan Steel Works
0.10
1.84
0.99
MTN Group Limited stock logo
MTNOY
MTN Group
0.42
0.83
N/A
Sino Biopharmaceutical Limited stock logo
SBMFF
Sino Biopharmaceutical
0.02
1.15
1.07

Institutional Ownership

CompanyInstitutional Ownership
Grasim Industries Limited stock logo
GRSXY
Grasim Industries
N/A
The Japan Steel Works, Ltd. stock logo
JPSWY
Japan Steel Works
N/A
MTN Group Limited stock logo
MTNOY
MTN Group
N/A
Sino Biopharmaceutical Limited stock logo
SBMFF
Sino Biopharmaceutical
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Grasim Industries Limited stock logo
GRSXY
Grasim Industries
25,929680.58 millionN/ANot Optionable
The Japan Steel Works, Ltd. stock logo
JPSWY
Japan Steel Works
5,115148.82 millionN/ANot Optionable
MTN Group Limited stock logo
MTNOY
MTN Group
16,2021.81 billionN/ANot Optionable
Sino Biopharmaceutical Limited stock logo
SBMFF
Sino Biopharmaceutical
25,80618.79 billionN/ANot Optionable

Recent News About These Companies

SBMFF Sino Biopharmaceutical Limited

Media Sentiment Over Time

Grasim Industries stock logo

Grasim Industries OTCMKTS:GRSXY

$19.61 0.00 (0.00%)
As of 05/12/2023

Grasim Industries Limited operates in fibre, yarn, pulp, chemicals, textile, fertilizers, and insulators businesses in India and internationally. The company operates through Viscose, Chemicals, Cement, Financial Services, and Others segments. It provides viscose staple fiber, a man-made biodegradable fiber for use in apparels, home textiles, dress materials, knit wear products, and non-woven applications; wood pulp products; viscose filament yarn, a natural fibre for manufacturing fabrics such as georgettes, crepes, chiffons, and others; and textile products, such as linen and wool. The company offers various chemical products, including chlor-alkali and epoxy resin products. In addition, it provides electrical insulators for transmission lines and substations, as well as equipment and railways. Further, the company offers grey cement; white cement; ready mix concrete; and cement-based putty. Additionally, it provides various financial services comprising non-bank financial, life insurance, asset management, housing finance, equity broking, wealth management, general insurance advisory, and health insurance services. The company involved in solar power designing, engineering procurement, and commissioning business. Grasim Industries Limited was incorporated in 1947 and is based in Mumbai, India.

Japan Steel Works stock logo

Japan Steel Works OTCMKTS:JPSWY

$25.10 -0.48 (-1.86%)
As of 06/13/2025 02:21 PM Eastern

The Japan Steel Works, Ltd. engages in the provision of industrial machinery products, and material and engineering business in Japan and internationally. It operates through Industrial Machinery Products Business, and Material and Engineering Business segments. The Industrial Machinery Products Business segment offers plastic production and processing machinery, such as pelletizers, film and sheet manufacturing equipment, and twin-screw extruders; molding machines including plastic injection molding, magnesium injection molding, and blow molding machines; and other machinery consists of excimer laser annealing systems, defense equipment, railway products, hot press devices, vacuum laminators, and deposit systems, as well as after-sales services for plastics, mobility, high-performance batteries, electronic devices, and defense applications. The Material and Engineering Business segment provides steel casting and forgings, such as reactor and steam generator parts, rotor shafts, turbine casings, die steel, steel rolls for steel manufacturing, and clad steel plates; and engineering and other services, including design and analysis, welded structures, inspection and survey, and hydrogen pressure accumulators and related products for use in power generation equipment, renewable energy, and infrastructure applications. The company offers photonics, composite materials, and metallic materials for use in semiconductors and electronic devices, cameras and sensing devices, aircraft and mobility components, and electronic parts. The Japan Steel Works, Ltd. was founded in 1907 and is headquartered in Shinagawa, Japan.

MTN Group stock logo

MTN Group OTCMKTS:MTNOY

$7.45 -0.16 (-2.10%)
As of 06/13/2025 02:10 PM Eastern

MTN Group Limited, together with its subsidiaries, provides mobile telecommunications services in South Africa, Nigeria, East Africa, West and Central Africa, and the Middle East and North Africa. The company offers data, voice and SMS, digital and fintech, interconnect, and roaming services, as well as sells mobile devices. It also provides network as a service, including subsea cables that offers international connectivity services; terrestrial and metro fiber networks; data centers and cable landing stations; and FTTx, towers, and radio access networks. The company also offers digital financial services, such as access payments, e-commerce, insurance, and lending and remittance services; enterprise services comprising manage networks, unified and cloud communication, security as a service, and Internet of Things; and API products and services for telecommunications, health, government, financial services, entertainment, and other sectors. MTN Group Limited was incorporated in 1994 and is based in Johannesburg, South Africa.

Sino Biopharmaceutical stock logo

Sino Biopharmaceutical OTCMKTS:SBMFF

$0.70 -0.02 (-3.31%)
As of 06/13/2025 01:14 PM Eastern

Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines, including anlotinib hydrochloride capsules under Focus V brand, penpulimab injection under Annike brand, efbemalenograstin alfa injection under Yilishu brand, pomalidomide capsules under Anyue brand, bevacizumab injection under Anbeisi brand, rituximab injection under Delituo brand, and trastuzumab for injection under Saituo brand; liver disease medications, such as magnesium isoglycyrrhizinate injection under Tianqing Ganmei brand and entecavir dispersible tablets under Runzhong brand; and respiratory system medicines comprising budesonide suspension for inhalation under Tianqing suchang brand and colistimethate sodium for injection under Tianyun brand. It also provides surgery/analgesia medicines, including flurbiprofen cataplasms under the brand Zepolas, limaprost tablets under the brand Kailitong, and recombinant human coagulation factor VIII for injection under the brand Anhengji; cardio-cerebral vascular medicines, such as irbesartan and hydrochlorothiazide tablets under the brand Yilunping and beraprost sodium tablets under the brand Kaina; and biosimilar medicines comprising adalimumab solution for injection under the brand Taibowei. In addition, the company develops oncology drugs, include benmelstobart, D-1553, TQ-B3139, and TQ-B3101; liver disease drugs, such as Lanifibranor and TQA2225/AP025; respiratory system drugs comprising TDI01, TQC2731, TCR1672, TQC3721, and TQH2722; and surgery/analgesia drugs, including PL-5, an antimicrobial peptide. Further, it is involved in the long-term investments; and healthcare and hospital business. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.